News
The binding kinetics of glycoform Fcs with FcγRIIIa was determined ... through glycoengineering to optimize their intended therapeutic effect. Monoclonal antibodies were produced in-house at ...
Cancer scientists say they have engineered a new type of super-strong antibody which could be used to boost the immune systems of patients fighting the disease. Experts from the University of ...
Until recently, scientists believed antibodies couldn't safely target lipids without risking harm to healthy tissues, since the same lipids that appear in viruses are widely distributed throughout ...
Engineering an antibody against flu with sticky staying power Aerosol treatment adheres to lung lining, blocks infection in mice Date: May 8, 2025 Source: Ohio State University Summary: Scientists ...
Cancer scientists engineer a new type of antibody which could be used to boost the immune systems of patients fighting disease. Cancer scientists say they have engineered a new type of super ...
The researchers showed "super antibodies" from the man's blood prevented toxic damage from neurotoxins found in the venoms of 19 different snake species, including mambas and cobras. Even so ...
The potential of monoclonal antibodies (mAbs) as therapies is indisputable. The current mAbs market is expected to be around ~USD 150 billion. In 2021, five out of the top 10 selling drugs were ...
Scientists identified antibodies that neutralized the poison in whole or in part from the bites of cobras, mambas and other deadly species. By Apoorva Mandavilli The video is just under two and a ...
Typically, it involves immunizing horses or sheep with venom from a single snake species and collecting the antibodies produced. While effective, this process could result in adverse reactions to ...
especially to support its OptiMAL mammalian antibody. Fusion’s chief executive Adrian Kinkaid said: “It is a testament to all our staff, from the bench to the board, that we have effectively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results